Spots Global Cancer Trial Database for Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer
Official Title: Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Adenocarcinoma of the Stomach or Gastroesophageal Junction. A Non-interventional Study
Study ID: NCT02305043
Interventions
Study Description
Brief Summary: The aim of this study is to identify biomarkers predicting response or resistance factors of a targeted therapy with trastuzumab in advanced gastric cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University Cancer Center Leipzig, Leipzig, , Germany
Contact Details
Name: Florian Lordick, Prof.
Affiliation: University Cancer Center Leipzig
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
